Sanofi
SEC CIK 1121404 · EDGAR
BoughtSold
Most active insiders at LTGO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foresite Capital Management V, LLC | 10% | $2.52M | — |
| 2 | Tananbaum James B. | Dir, 10% | $2.52M | — |
| 3 | 5AM Ventures VI, L.P. | 10% | — | — |
| 4 | Westlake BioPartners Fund I, L.P. | 10% | — | — |
| 5 | SEIDENBERG BETH C | Dir, 10% | — | — |
| 6 | Sanofi | 10% | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-08-12 08:18 | 2026-08-10 | LTGO | Latigo Biotherapeutics, Inc. | Sanofi | 10% | C - Cnv Deriv | — | +672.8K | 672.8K | +6,727,780% | — |
| DI | 2026-08-07 15:45 | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | Sanofi | 10% | C - Cnv Deriv | — | +782.9K | 782.9K | New | — |
| DI | 2026-08-07 15:45 | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | Sanofi | 10% | P - Purchase | $17.00 | +300.0K | 1.08M | +38% | +$5.10M |
Purchase Sale Sale after option exercise All abbreviations